OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

NCT00902837 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Osteoarthritis

Interventions

DRUG: Oxycodone naloxone prolonged release tablets (OXN)
DRUG: oxycodone prolonged release tablet
DRUG: oxycodone naloxone tablet

Sponsor

Mundipharma Research GmbH & Co KG